DIPG, Ependymomas, ETMR, High-grade gliomas, Pediatric brain tumors, Translational neuro-oncology
- Pediatric Hematology/Oncology, 2019
- Pediatrics, 2013
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Pediatric Hematology/Oncology, 2017
- Boston Children's Hospital, Pediatrics, 2013
- Medical University of Graz, Austria, 2004
Dr. Mariella Filbin earned her MD and PhD in biochemistry and molecular biology from the Medical University of Graz, Austria. After a pediatric residency at Boston Children’s Hospital, she completed a fellowship in pediatric hematology/oncology at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She joined the faculty at Dana-Farber/Boston Children's as a pediatric neuro-oncologist in July 2017. In addition to her role in the treatment of patients with brain tumors, her research focuses on establishing cellular networks of tumor dependencies in pediatric brain tumors with the goal of finding new targeted therapies. Current areas of emphasis are: (1) utilizing single-cell transcriptomics to determine the tumor architecture and heterogeneity in pediatric brain tumors and (2) exploring the downstream effects of epigenetic driver mutations and their potential therapeutic applications in DIPG and high-grade gliomas.